Observational studyBiomolecules2025

Inflammatory Biomarkers for Thrombotic Risk Assessment in Multiple Myeloma Patients on IMiD/aCD38-Based Regimens: Insights from a Prospective Observational Study.

Cirino Botta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.